The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted access.
Drug Prices To Get ‘More Expensive’ Under Trump’s EU Trade Deal As Pharma Faces Billions In Added Costs: Report
